The global Viral Clearance Service Market size is expected to reach USD 1,967.68 Million by 2028 at a CAGR of 21.9%, according to the latest report by Reports and Data. Key factors driving market revenue growth include growing global healthcare burden due to increasing prevalence of chronic diseases, increasing private and public funding for biopharmaceutical RD, rising demand for biologics, and rapid rise in drug discovery and development processes. Technological advancements in nanofiltration and other viral removal methods are also expected to contribute significantly to revenue growth of the market over the forecast period.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/4001
Viral clearance entails removal of viral contamination from biological products with the application of customized membranes or chromatography. Viral contamination is a common complication of majority human- and animal-derived biopharmaceuticals. Viruses can be accidently introduced into the manufacturing processes of biological products and can originate from cell lines, cell culture media or from equipment. It is imperative to perform viral testing studies and integrate viral clearance methods into manufacturing processes. Viral clearance studies are an important part of process validation and ensuring safety of drugs. Biopharmaceutical manufacturers have devised alternative methods to overcome viral contaminations caused by cell lines or culture media and this is expected to be a key factor driving market revenue growth over the forecast period.
Browse Full Report Description + Research Methodology + Table of Content + Infographics @https://www.reportsanddata.com/report-detail/viral-clearance-market
Asia Pacific is expected to lead the market growth over the coming years owing to rapid advancements in healthcare sector in APAC countries such as India, China, and Japan. North America is anticipated to register highest market growth over the forecast period attributed to increasing availability of robust healthcare and clinical settings, legalization of medical marijuana, favorable reimbursement scenario, presence of key market players, and rapid technological advancements in the region.
Request a customization on the report @https://www.reportsanddata.com/request-customization-form/4001
Some Key Highlights from the Report:
- Viral removal segment is expected to account for a significant revenue share in the global market over the forecast period owing to increasing research and development activities in biopharmaceutical sector, rising adoption of this method in drug discovery, and development of efficient viral removal procedures.
- Vaccines segment is expected to register rapid revenue CAGR over the forecast period owing to growing global demand for vaccines and therapeutics due to increasing healthcare burden as a result of rising prevalence of chronic and infectious diseases.
- CROs segment is expected to register considerable revenue growth over the forecast period owing to increasing investment by CROs for advanced drug discovery and development platforms and increasing outsourcing by pharmaceuticals and biotechnology companies for drug discovery services.
- North America is expected to account for largest share in the global market in terms of revenue over the forecast period owing to increasing developments in the biopharmaceutical industry, rising private and public funding for stem cell research, increasing demand and production of monoclonal antibodies, and presence of robust healthcare infrastructure in countries in the region.
- Major companies in the market include Charles River Laboratories International, Inc., WuXi Biologics, Lonza Group, Merck KGaA, Sigma-Aldrich Corporation, Avance Biosciences Inc., BSL BIOSERVICE, Clean Cells, SGS S.A., Texcell, Inc., and Vironova Biosafety.
- In September 2020, Merck announced expansion of its Singapore biosafety testing laboratory services. The services enable customers to carry out viral clearance studies to ensure safety and quality of their drugs is high during clinical development process.
For the purpose of this report, Reports and Data has segmented the global Viral Clearance Service Market based on method, application, end-use, and region:
Method Outlook (Revenue, USD Million; 2018-2028)
- Viral Removal
- Chromatography
- Nanofiltration
- Precipitation
- Viral Inactivation
- Low pH
- Solvent Detergent Method
- Pasteurization
- Other Viral Inactivation Methods
- Viral Detection
Application Outlook (Revenue, USD Million; 2018-2028)
- Recombinant Proteins
- Blood and Blood Products
- Vaccines
- Other Applications
End-use Outlook (Revenue, USD Million; 2018-2028)
- Pharmaceutical Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic Research Institutes
- Others
Regional Outlook (Revenue, USD Million; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Growing popularity of over-the-counter medications driving market growth
Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.
Restriction on product launches and RD activities to hamper market growth
Imposition of strict government regulations and shortage of funds have put a halt on the product launches and RD activities and are expected to restrain market growth over the forecast period. In addition, launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering market growth.
Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/video